bioRxivCell BiologyPreprint
Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modeling
R. Muhammad Irfanur, T. Ito, D. Shimojo, K. Arimoto, K. Onodera, R. Okada, T. Nagashima, K. Yamamoto, Z. Khatun, H. Okano, H. Sakurai, K. Shimizu, M. Doyu, Y. Okada
Abstract
Pathophysiological analysis and drug discovery targeting human diseases require disease models that suitably recapitulate patients pathology. Disease-specific human induced pluripotent stem cells (hiPSCs) can potentially recapitulate disease pathology more accurately than existing disease models when differentiated into affected cell types. Thus, successful modeling of muscular diseases requires efficient differentiation of hiPSCs into skeletal muscles. hiPSCs transduced with doxycycline-inducible MYOD1 (MYOD1-hiPSCs) have been widely used; however, they require time- and labor-consuming clonal selection procedures, and clonal variations must be overcome. Moreover, their functionality to exhibit muscular contraction has never been reported. Here, we demonstrated that bulk MYOD1- hiPSCs established with puromycin selection, but not with G418 selection, showed high differentiation efficiency, generating more than 80% Myogenin (MyoG)+ and Myosin heavy chain (MHC)+ muscle cells within seven days. Interestingly, bulk MYOD1-hiPSCs exhibited average differentiation properties compared with those of clonally established MYOD1- hiPSCs, suggesting that the bulk method may minimize the effects of clonal variations. Finally, three-dimensional muscle tissues were fabricated from bulk MYOD1-hiPSCs, which exhibited contractile force upon electrical pulse stimulation, indicating their functionality. Together, the findings indicate that our bulk differentiation requires less time and labor than existing methods, efficiently generates contractible skeletal muscles, and facilitates the generation of muscular disease models. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=167 SRC="FIGDIR/small/468571v1_ufig1.gif" ALT="Figure 1"> View larger version (45K): org.highwire.dtl.DTLVardef@12c091eorg.highwire.dtl.DTLVardef@ad1ccorg.highwire.dtl.DTLVardef@53ba90org.highwire.dtl.DTLVardef@fd65f5_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Myogenesis modelled by human pluripotent stem cells uncovers Duchenne muscular dystrophy phenotypes prior to skeletal muscle commitment
Virginie Mournetas, Emmanuelle Massouridès, … Christian Pinset·Journal of Cachexia Sarcopenia and MusclePeer-reviewed·Feb 1, 2021
- iPSC-derived skeletal muscle spheroids for Duchenne Muscular Dystrophy modeling
Joyce Esposito, Felipe de Souza Leite, … Mayana Zatz·Skeletal MusclePeer-reviewed·May 2, 2026
- Human iPSC-derived muscle cells as a new model for investigation of EDMD1 pathogenesis.
Marta Lisowska, Marta Rowińska, … Katarzyna Piekarowicz·International Journal of Molecular SciencesPeer-reviewed·Feb 12, 2025
- Human iPS Cells Derived Skeletal Muscle Progenitor Cells Promote Myoangiogenesis and Restore Dystrophin in Duchenne Muscular Dystrophic Mice
w. xuan, M. Khan, M. Ashraf·Stem Cell Research & TherapyPeer-reviewed·Feb 12, 2021
- Prednisolone rescues Duchenne Muscular Dystrophy phenotypes in human pluripotent stem cells-derived skeletal muscle in vitro
Z. Al Tanoury, J. F. Zimmermann, … O. Pourquie·bioRxiv·Oct 29, 2020
- Skeletal muscle cells derived from induced pluripotent stem cells: a platform for limb girdle muscular dystrophies.
c. Bruge, M. GEOFFROY, … X. Nissan·bioRxiv·May 8, 2022